Plasma GFAP associates with secondary Alzheimer's pathology in Lewy body disease
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma GFAP associates with secondary Alzheimer's pathology in Lewy body disease
Authors
Keywords
-
Journal
Annals of Clinical and Translational Neurology
Volume 10, Issue 5, Pages 802-813
Publisher
Wiley
Online
2023-04-01
DOI
10.1002/acn3.51768
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasma p‐tau231, p‐tau181, PET Biomarkers, and Cognitive Change in Older Adults
- (2022) Pierre‐François Meyer et al. ANNALS OF NEUROLOGY
- Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer’s disease, frontotemporal dementia and progressive supranuclear palsy
- (2022) Leonidas Chouliaras et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change
- (2022) Denis S. Smirnov et al. ACTA NEUROPATHOLOGICA
- Appropriateness of Applying Cerebrospinal Fluid Biomarker Cutoffs from Alzheimer’s Disease to Parkinson’s Disease
- (2022) Sarah Weinshel et al. Journal of Parkinsons Disease
- Elevated plasma phosphorylated tau 181 in amyotrophic lateral sclerosis
- (2022) Katheryn A.Q. Cousins et al. ANNALS OF NEUROLOGY
- Non-tremor motor dysfunction in Lewy body dementias is associated with AD biomarkers
- (2022) Ian M. Walker et al. PARKINSONISM & RELATED DISORDERS
- Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance
- (2022) Alexa Pichet Binette et al. Alzheimers & Dementia
- CSF Biomarkers of Alzheimer Disease in Patients With Concomitant α-Synuclein Pathology
- (2022) Katheryn Alexandra Quilico Cousins et al. NEUROLOGY
- Natural speech markers of Alzheimer's disease co-pathology in Lewy body dementias
- (2022) Sanjana Shellikeri et al. PARKINSONISM & RELATED DISORDERS
- Distinguishing Frontotemporal Lobar Degeneration Tau From TDP-43 Using Plasma Biomarkers
- (2022) Katheryn A. Q. Cousins et al. JAMA Neurology
- Neuropathological validation of plasma GFAP
- (2022) Andréa Lessa Benedet et al. Alzheimers & Dementia
- Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease
- (2021) Pratishtha Chatterjee et al. Translational Psychiatry
- Plasma p‐tau181, p‐tau217, and other blood‐based Alzheimer's disease biomarkers in a multi‐ethnic, community study
- (2021) Adam M. Brickman et al. Alzheimers & Dementia
- Cognitive Profile and Markers of Alzheimer Disease–Type Pathology in Patients With Lewy Body Dementias
- (2021) Erica Howard et al. NEUROLOGY
- Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
- (2021) Claudia Cicognola et al. Alzheimers Research & Therapy
- Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease
- (2021) Joana B Pereira et al. BRAIN
- Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study
- (2021) Elisabeth H Thijssen et al. LANCET NEUROLOGY
- A multicentre validation study of the diagnostic value of plasma neurofilament light
- (2021) Nicholas J. Ashton et al. Nature Communications
- Are Parkinson’s Disease Patients the Ideal Preclinical Population for Alzheimer’s Disease Therapeutics?
- (2021) Thomas F. Tropea et al. Journal of Personalized Medicine
- Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy Bodies
- (2021) Maria C. Gonzalez et al. JAMA Neurology
- Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
- (2021) Andréa L. Benedet et al. JAMA Neurology
- Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration
- (2020) Elisabeth H. Thijssen et al. NATURE MEDICINE
- Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
- (2020) Thomas K Karikari et al. LANCET NEUROLOGY
- Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease
- (2020) David J. Irwin et al. ANNALS OF NEUROLOGY
- Head‐to‐head comparison of clinical performance of CSF phospho‐tau T181 and T217 biomarkers for Alzheimer's disease diagnosis
- (2020) Thomas K. Karikari et al. Alzheimers & Dementia
- Assessment of Racial Disparities in Biomarkers for Alzheimer Disease
- (2019) John C. Morris et al. JAMA Neurology
- Plasma biomarkers of astrocytic and neuronal dysfunction in early‐ and late‐onset Alzheimer's disease
- (2019) Fanny M. Elahi et al. Alzheimers & Dementia
- Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders
- (2019) Sara Hall et al. MOVEMENT DISORDERS
- Integrated neurodegenerative disease autopsy diagnosis
- (2018) Edward B. Lee ACTA NEUROPATHOLOGICA
- Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?
- (2018) Kurt A. Jellinger et al. BMC Medicine
- CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders
- (2018) David J. Irwin et al. NEUROLOGY
- Diagnosis and management of dementia with Lewy bodies
- (2017) Ian G. McKeith et al. NEUROLOGY
- Race modifies the relationship between cognition and Alzheimer’s disease cerebrospinal fluid biomarkers
- (2017) Jennifer C. Howell et al. Alzheimers Research & Therapy
- Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment
- (2016) Olivia A. Skrobot et al. BRAIN
- Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies
- (2016) A W Lemstra et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration
- (2015) Aiko Ishiki et al. JOURNAL OF NEUROCHEMISTRY
- Neuroinflammation in Alzheimer's disease
- (2015) Michael T Heneka et al. LANCET NEUROLOGY
- A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank
- (2013) Jon B. Toledo et al. Alzheimers & Dementia
- Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease
- (2013) Willem Kamphuis et al. NEUROBIOLOGY OF AGING
- A harmonized classification system for FTLD-TDP pathology
- (2011) Ian R. A. Mackenzie et al. ACTA NEUROPATHOLOGICA
- National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
- (2011) Thomas J. Montine et al. ACTA NEUROPATHOLOGICA
- Cortical α-synuclein load is associated with amyloid-β plaque burden in a subset of Parkinson’s disease patients
- (2008) Tammaryn Lashley et al. ACTA NEUROPATHOLOGICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation